يعرض 1 - 13 نتائج من 13 نتيجة بحث عن '"Ulrik N. Lassen"', وقت الاستعلام: 0.39s تنقيح النتائج
  1. 1
    Academic Journal
    Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib

    المؤلفون: James C. H. Yang, Marcia S. Brose, Gilberto Castro, Edward S. Kim, Ulrik N. Lassen, Serge Leyvraz, Alberto Pappo, Fernando López-Ríos, John A. Reeves, Marc Fellous, Frédérique Penault-Llorca, Erin R. Rudzinski, Ghazaleh Tabatabai, Gilles Vassal, Alexander Drilon, Jonathan Trent

    المصدر: BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)

    مصطلحات موضوعية: Larotrectinib, NTRK gene fusions, TRK fusion, Non-interventional study, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://doaj.org/toc/1471-2407

    URL الوصول: https://doaj.org/article/d03b60bd6de0450a90283154c262afe5

    View record in DOAJ Full Text Finder

    أضف إلى المفضلة
  2. 2
    Data from Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity

    المؤلفون: Ulrik N. Lassen, Martin Weisser, Birgit Bossenmaier, Francesca Michielin, Celine Adessi, Lori Steiner, Maitram Nguyen, Rajiv Dua, Suzana Vega-Harring, Ian James, Georgina Meneses-Lorente, Maurizio Ceppi, Marlene Thomas, Sabine Wilson, Jan H.M. Schellens, Sang-We Kim, Enriqueta Felip, Antonio Calles, Ji-Youn Han, Stefan Sleijfer, Maja J. De Jonge, Marlies H.G. Langenberg, Martijn P. Lolkema, Andres Cervantes, Tania Fleitas, Alvaro Taus, Maria Martinez-Garcia, Morten Mau-Sorensen, Emile E. Voest, Wolfgang Jacob, Didier Meulendijks

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::318985d039f3af8aedc62fa7c6e52f8e
    https://doi.org/10.1158/1078-0432.c.6527064.v1

    View record in OpenAIRE

    أضف إلى المفضلة
  3. 3
    Figure 1, Figure 2, Table 1, Table 2, Table 3, Table 4, Table 5, Table 6 from First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid Tumors

    المؤلفون: Ulrik N. Lassen, Martin Weisser, Jan H.M. Schellens, Birgit Bossenmaier, Keelara Abiraj, Francesca Michielin, Celine Adessi, Ian James, Georgina Meneses-Lorente, Maurizio Ceppi, Marlene Thomas, Morten Mau Soerensen, Stefan Sleijfer, Maja J. De Jonge, Andres Cervantes, Tania Fleitas Kanonnikoff, Marlies H.G. Langenberg, Emile E. Voest, Martijn P. Lolkema, Alvaro Taus, Maria Martinez-Garcia, Wolfgang Jacob, Didier Meulendijks

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b72d52ddfd1a32c36eaa2245c001d135
    https://doi.org/10.1158/1078-0432.22461363

    View record in OpenAIRE

    أضف إلى المفضلة
  4. 4
    Table S1, Table S2 from Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity

    المؤلفون: Ulrik N. Lassen, Martin Weisser, Birgit Bossenmaier, Francesca Michielin, Celine Adessi, Lori Steiner, Maitram Nguyen, Rajiv Dua, Suzana Vega-Harring, Ian James, Georgina Meneses-Lorente, Maurizio Ceppi, Marlene Thomas, Sabine Wilson, Jan H.M. Schellens, Sang-We Kim, Enriqueta Felip, Antonio Calles, Ji-Youn Han, Stefan Sleijfer, Maja J. De Jonge, Marlies H.G. Langenberg, Martijn P. Lolkema, Andres Cervantes, Tania Fleitas, Alvaro Taus, Maria Martinez-Garcia, Morten Mau-Sorensen, Emile E. Voest, Wolfgang Jacob, Didier Meulendijks

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::804d643b37a2cdf6fd277ce1fd5c048c
    https://doi.org/10.1158/1078-0432.22468827

    View record in OpenAIRE

    أضف إلى المفضلة
  5. 5
    Supplemental Figure S1 and Table S1 from A Phase I Monotherapy Study of RG7212, a First-in-Class Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Cancers

    المؤلفون: Glenwood D. Goss, Mark DeMario, Ka Wang, David Geho, Tiantom Jarutat, Suzana M. Vega-Harring, Markus Roessler, Hua Zhong, Dean Bottino, Kathleen J. Schostack, Mary E. Simcox, Aaron R. Hansen, Derek J. Jonker, Jan H.M. Schellens, Morten Mau-Sorensen, Vaios Karanikas, Lilian L. Siu, Didier Meulendijks, Ulrik N. Lassen

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e0ab408c3772903e1549f808a8c8771
    https://doi.org/10.1158/1078-0432.22460889.v1

    View record in OpenAIRE

    أضف إلى المفضلة
  6. 6
    Data from A Phase I Monotherapy Study of RG7212, a First-in-Class Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Cancers

    المؤلفون: Glenwood D. Goss, Mark DeMario, Ka Wang, David Geho, Tiantom Jarutat, Suzana M. Vega-Harring, Markus Roessler, Hua Zhong, Dean Bottino, Kathleen J. Schostack, Mary E. Simcox, Aaron R. Hansen, Derek J. Jonker, Jan H.M. Schellens, Morten Mau-Sorensen, Vaios Karanikas, Lilian L. Siu, Didier Meulendijks, Ulrik N. Lassen

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f1556d4bf5a8a7e541e0458a0379e4b
    https://doi.org/10.1158/1078-0432.c.6524631

    View record in OpenAIRE

    أضف إلى المفضلة
  7. 7
    Data from First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid Tumors

    المؤلفون: Ulrik N. Lassen, Martin Weisser, Jan H.M. Schellens, Birgit Bossenmaier, Keelara Abiraj, Francesca Michielin, Celine Adessi, Ian James, Georgina Meneses-Lorente, Maurizio Ceppi, Marlene Thomas, Morten Mau Soerensen, Stefan Sleijfer, Maja J. De Jonge, Andres Cervantes, Tania Fleitas Kanonnikoff, Marlies H.G. Langenberg, Emile E. Voest, Martijn P. Lolkema, Alvaro Taus, Maria Martinez-Garcia, Wolfgang Jacob, Didier Meulendijks

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a0c125365082713b8cabafa6017be82
    https://doi.org/10.1158/1078-0432.c.6524775.v1

    View record in OpenAIRE

    أضف إلى المفضلة
  8. 8
    Supplementary Figure 1, Figure 2, Table 1, Table 2, Table 3, Table 4, Table 5, Table 6 from First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid Tumors

    المؤلفون: Ulrik N. Lassen, Martin Weisser, Jan H.M. Schellens, Birgit Bossenmaier, Keelara Abiraj, Francesca Michielin, Celine Adessi, Ian James, Georgina Meneses-Lorente, Maurizio Ceppi, Marlene Thomas, Morten Mau Soerensen, Stefan Sleijfer, Maja J. De Jonge, Andres Cervantes, Tania Fleitas Kanonnikoff, Marlies H.G. Langenberg, Emile E. Voest, Martijn P. Lolkema, Alvaro Taus, Maria Martinez-Garcia, Wolfgang Jacob, Didier Meulendijks

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::543fc99dd1aedd886d7418002de3e9d5
    https://doi.org/10.1158/1078-0432.22461360

    View record in OpenAIRE

    أضف إلى المفضلة
  9. 9
    Figure S1, Figure S2, Figure S3, Figure S4, Figure S5, Figure S6 from Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity

    المؤلفون: Ulrik N. Lassen, Martin Weisser, Birgit Bossenmaier, Francesca Michielin, Celine Adessi, Lori Steiner, Maitram Nguyen, Rajiv Dua, Suzana Vega-Harring, Ian James, Georgina Meneses-Lorente, Maurizio Ceppi, Marlene Thomas, Sabine Wilson, Jan H.M. Schellens, Sang-We Kim, Enriqueta Felip, Antonio Calles, Ji-Youn Han, Stefan Sleijfer, Maja J. De Jonge, Marlies H.G. Langenberg, Martijn P. Lolkema, Andres Cervantes, Tania Fleitas, Alvaro Taus, Maria Martinez-Garcia, Morten Mau-Sorensen, Emile E. Voest, Wolfgang Jacob, Didier Meulendijks

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::135623d1e0a77e3729af54381eb2fbbb
    https://doi.org/10.1158/1078-0432.22468830

    View record in OpenAIRE

    أضف إلى المفضلة
  10. 10
    Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion–Positive Lung Cancers

    المؤلفون: Alexander Drilon, Daniel S. W. Tan, Ulrik N. Lassen, Serge Leyvraz, Yongmei Liu, Jyoti D. Patel, Lee Rosen, Benjamin Solomon, Ricarda Norenberg, Laura Dima, Nicoletta Brega, Lin Shen, Victor Moreno, Shivaani Kummar, Jessica J. Lin

    المصدر: Drilon, A, Tan, D S W, Lassen, U N, Leyvraz, S, Liu, Y, Patel, J D, Rosen, L, Solomon, B, Norenberg, R, Dima, L, Brega, N, Shen, L, Moreno, V, Kummar, S & Lin, J J 2022, ' Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion–Positive Lung Cancers ', JCO Precision Oncology, vol. 6, e2100418 . https://doi.org/10.1200/PO.21.00418

    مصطلحات موضوعية: Adult, Male, Cancer Research, Lung Neoplasms, Middle Aged, Pyrimidines, Treatment Outcome, Oncology, Humans, Pyrazoles, Female, Gene Fusion, Protein Kinases, Aged

    وصف الملف: application/pdf

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc1b3ac2b9e98e4444d601a84aaed822
    https://doi.org/10.1200/po.21.00418

    View record in OpenAIRE

    أضف إلى المفضلة
  11. 11
    Abstract CT228: Concordance between tissue and circulating tumor DNA (ctDNA) testing for neurotrophic tyrosine receptor kinase (NTRK) gene fusions in larotrectinib (laro) clinical trials

    المؤلفون: Erin R. Rudzinski, Marc Ladanyi, Lauren L. Ritterhouse, Felix Sahm, Ricarda Norenberg, Hong Zheng, Chi Chen, Vadim Bernard-Gauthier, Nicoletta Brega, Cornelis M. van Tilburg, Jessica J. Lin, Marcia S. Brose, Ulrik N. Lassen, Ray McDermott, Theodore W. Laetsch, David S. Hong, Alexander Drilon, Sinchita Roy-Chowdhuri

    المصدر: Cancer Research. 83:CT228-CT228

    مصطلحات موضوعية: Cancer Research, Oncology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b5c3a1927c36dfdf70eef05368cb7680
    https://doi.org/10.1158/1538-7445.am2023-ct228

    View record in OpenAIRE

    أضف إلى المفضلة
  12. 12
    CTNI-62. LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS

    المؤلفون: Sébastien Perreault, Alexander Drilon, Ulrik N Lassen, Birgit Geoerger, Karsten Nysom, Ingrid Øra, Igor T Gavrilovic, Ricarda Norenberg, Vadim Bernard-Gauthier, Esther De La Cuesta, Theodore W Laetsch, François Doz, Cornelis M Van Tilburg

    المصدر: Neuro-Oncology. 24:vii87-vii87

    مصطلحات موضوعية: Cancer Research, Oncology, Neurology (clinical)

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f67b0d4eaf973cf3a5a6f218e1a6e4d6
    https://doi.org/10.1093/neuonc/noac209.327

    View record in OpenAIRE

    أضف إلى المفضلة
  13. 13
    Abstract CT545: Variability in NTRK gene fusions does not appear to impact response to larotrectinib

    المؤلفون: Marc Ladanyi, Sinchita Roy-Chowdhuri, Lauren Ritterhouse, Felix Sahm, Ricarda Norenberg, Kui Shen, Chi Chen, Marc Fellous, Nicoletta Brega, Cornelis M. van Tilburg, Jessica J. Lin, Marcia S. Brose, Ulrik N. Lassen, Ray McDermott, Theodore W. Laetsch, David S. Hong, Alexander Drilon, Erin R. Rudzinski

    المصدر: Cancer Research. 82:CT545-CT545

    مصطلحات موضوعية: Cancer Research, Oncology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e1e01bbbcf71063e6cc6d15c2efd3b73
    https://doi.org/10.1158/1538-7445.am2022-ct545

    View record in OpenAIRE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء